GraniteShares 2x Long ISRG Daily ETFISUL

The GraniteShares 2x Long ISRG Daily ETF (ISUL) is trading on Nasdaq under a mandate that sounds like a trader’s dream: double the daily moves of Intuitive Surgical’s shares, reset every day, and wrapped in the kind of leverage that usually shows up in a hedge fund’s client letter, not a retail ticker. The fund’s listing is live, but the real work happens in the swap agreements that sit between you and the stock, because ISUL doesn’t actually hold Intuitive Surgical shares itself. Instead, it holds contracts with a counterparty that promises to deliver the 2x return, and for that privilege you pay 0.95% per year whether the market is open or not. The Nasdaq page shows the ticker is up and running, but the fund’s holdings page is still a ghost town-no portfolio snapshots, no swap counterparty disclosures, just a promise and a fee. (source: Nasdaq, https://www.nasdaq.com/market-activity/etf/isul)

The fund’s expense ratio of 0.95% is the only number that feels real in this arrangement, because everything else-daily reset mechanics, swap terms, counterparty credit risk-is hidden behind the marketing curtain. GraniteShares pitches ISUL as a way to magnify exposure to Intuitive Surgical, but the fund’s basket is effectively a set of derivative IOUs rather than a slice of the robotics giant. If you want the stock, buy it directly; if you want the drama of a 2x daily reset, you’re buying a swap contract dressed in an ETF wrapper, and the issuer’s glossy slides won’t tell you how much the swap costs when the market turns. (source: SEC EDGAR fund search for ISUL, https://www.sec.gov/edgar/search/#/q=ISUL)

The SEC’s EDGAR search confirms ISUL exists as a registered fund, but the filing doesn’t yet reveal the swap counterparty’s identity or the fund’s latest portfolio composition, which means the only concrete facts we have are the ticker, the expense ratio, and the Nasdaq listing. The FINRA Fund Analyzer tool is silent on ISUL’s current AUM or liquidity metrics, so we can’t say whether this is a quiet niche product or a ticking liquidity experiment. The fund’s mandate is clear on paper-2x long, daily reset-but the operational reality is a black box until the issuer files the next update. Until then, the fund remains a marketing promise backed by a fee and a swap, not a transparent basket of stocks. (source: SEC EDGAR fund search for ISUL, https://www.sec.gov/edgar/search/#/q=ISUL; FINRA Fund Analyzer, https://tools.finra.org/fund_analyzer/)

What changed this week: ISUL’s Nasdaq listing went live, but the fund’s portfolio disclosures and swap counterparty details remain unpublished in the evidence pack. The only numbers we can cite are the 0.95% expense ratio and the fact that the ticker is trading on Nasdaq. There is no evidence of recent filings, earnings, or portfolio updates that would clarify the fund’s current holdings or counterparty risk. (source: Nasdaq, https://www.nasdaq.com/market-activity/etf/isul; SEC EDGAR fund search for ISUL, https://www.sec.gov/edgar/search/#/q=ISUL)

What remains unproven: the swap counterparty’s identity, the fund’s latest portfolio holdings, the swap agreement terms, and the fund’s current AUM or liquidity metrics. The evidence does not confirm whether ISUL’s daily reset mechanics are working as advertised or whether the fee is justified by the fund’s structure. Until the issuer files a portfolio snapshot or swap disclosure, the fund’s true mechanics remain a matter of trust rather than transparency. (source: SEC EDGAR fund search for ISUL, https://www.sec.gov/edgar/search/#/q=ISUL; FINRA Fund Analyzer, https://tools.finra.org/fund_analyzer/)